Literature DB >> 16307454

A rabbit model for sublingual drug delivery: comparison with human pharmacokinetic studies of propranolol, verapamil and captopril.

Manisha M Dali1, Paul A Moench, Neil R Mathias, Paul I Stetsko, Christopher L Heran, Ronald L Smith.   

Abstract

A rabbit model for investigating sublingual drug absorption was established yielding results consistent with clinical data reported in the literature. Using propranolol as a model compound the effect of formulation and dosing variables was explored as a means to characterize the limiting parameters of this model. In addition, verapamil and captopril were selected as reference compounds to compare this model to sublingual absorption in humans. Rabbits were dosed sublingually and systemic absorption was measured over time. Sublingual absorption of propranolol was dependent on dosing solution pH and volume. Intra-oral spray device did not affect the overall exposure compared to instillation using a syringe. Despite species and dosing regimen differences the relative bioavailabilities of propranolol and verapamil were very similar in rabbits and humans. In contrast, captopril absorption from the sublingual cavity of rabbits was low and did not agree with that observed in man. Here we report a sublingual rabbit model of drug delivery and its potential utility in preclinical development of intra-oral dosage forms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16307454     DOI: 10.1002/jps.20312

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Distribution of propranolol in periocular tissues: a comparison of topical and systemic administration.

Authors:  Jinsong Hao; Michael B Yang; Hongzhuo Liu; S Kevin Li
Journal:  J Ocul Pharmacol Ther       Date:  2011-08-02       Impact factor: 2.671

2.  Sublingual Diffusion of Epinephrine Microcrystals from Rapidly Disintegrating Tablets for the Potential First-Aid Treatment of Anaphylaxis: In Vitro and Ex Vivo Study.

Authors:  Mutasem M Rawas-Qalaji; Shima Werdy; Ousama Rachid; F Estelle R Simons; Keith J Simons
Journal:  AAPS PharmSciTech       Date:  2015-03-04       Impact factor: 3.246

3.  Formulation and in vivo evaluation of orally disintegrating tablets of clozapine/hydroxypropyl-β-cyclodextrin inclusion complexes.

Authors:  Fan Zeng; Ling Wang; Wenjing Zhang; Kejing Shi; Li Zong
Journal:  AAPS PharmSciTech       Date:  2013-05-07       Impact factor: 3.246

4.  Comparative bioavailability study following a single dose intravenous and buccal administration of remdesivir in rabbits.

Authors:  Lajos Szente; Tibor Renkecz; Dávid Sirok; János Stáhl; Gábor Hirka; István Puskás; Tamás Sohajda; Éva Fenyvesi
Journal:  Int J Pharm       Date:  2022-04-11       Impact factor: 6.510

5.  Exploitation of Design-of-Experiment Approach for Design and Optimization of Fast-Disintegrating Tablets for Sublingual Delivery of Sildenafil Citrate with Enhanced Bioavailability Using Fluid-Bed Granulation Technique.

Authors:  Amer S AlAli; Mohammed F Aldawsari; Ahmed Alalaiwe; Bjad K Almutairy; Ramadan Al-Shdefat; Ismail A Walbi; Mohamed H Fayed
Journal:  Pharmaceutics       Date:  2021-06-12       Impact factor: 6.321

6.  Scalable flibanserin nanocrystal-based novel sublingual platform for female hypoactive sexual desire disorder: engineering, optimization adopting the desirability function approach and in vivo pharmacokinetic study.

Authors:  Marianne J Naguib; Amal I A Makhlouf
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

7.  Development and evaluation of fixed dose bi therapy sublingual tablets for treatment stress hypertension and anxiety.

Authors:  Mohamed A El-Nabarawi; Saadia A Tayel; Nadia A Soliman; Hadel A Abo Enin
Journal:  J Pharm Bioallied Sci       Date:  2013-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.